IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Drug Discovery Today: Disease Models

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on September 3, 2024

Impact Score

2023-2024

0.00

h-Index

2023-2024

 33

Rank

2023-2024

 7950

SJR

2023-2024

 0.665

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Drug Discovery Today: Disease Models
Abbreviation Drug Discov. Today: Dis. Models
Publication Type Journal
Subject Area, Categories, Scope Drug Discovery (Q2); Molecular Medicine (Q3)
h-index 33
Overall Rank/Ranking 7950
SCImago Journal Rank (SJR) 0.665
Impact Score 0.00
Publisher Elsevier Ltd
Country United Kingdom
ISSN 17406757
Best Quartile Q2
Coverage History 2004-2020




About Drug Discovery Today: Disease Models


Drug Discovery Today: Disease Models is a journal covering the technologies/fields/categories related to Drug Discovery (Q2); Molecular Medicine (Q3). It is published by Elsevier Ltd. The overall rank of Drug Discovery Today: Disease Models is 7950. According to SCImago Journal Rank (SJR), this journal is ranked 0.665. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 33. The best quartile for this journal is Q2.

The ISSN of Drug Discovery Today: Disease Models journal is 17406757. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Drug Discovery Today: Disease Models is cited by a total of 64 articles during the last 3 years (Preceding 2023).


Drug Discovery Today: Disease Models Impact IF 2023-2024


The Impact IF 2023 of Drug Discovery Today: Disease Models is 0.00, which is computed in 2024 as per its definition. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Drug Discovery Today: Disease Models Impact IF 2024 Prediction


Impact IF 2023 of Drug Discovery Today: Disease Models is 0.00. If the same downward trend persists, Impact IF may fall in 2024 as well.


Impact IF Trend


Year wise Impact IF of Drug Discovery Today: Disease Models. Based on Scopus data.


Year Impact IF
2023/2024 Coming Soon
2023 0.00
2022 1.78
2021 1.20
2020 0.93
2019 0.46
2018 0.22
2017 0.37
2016 0.81
2015 0.63
2014 0.42

Drug Discovery Today: Disease Models h-index


  Table Setting

Drug Discovery Today: Disease Models has an h-index of 33. It means 33 articles of this journal have more than 33 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Drug Discovery Today: Disease Models ISSN


The ISSN of Drug Discovery Today: Disease Models is 17406757. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Drug Discovery Today: Disease Models Rank and SCImago Journal Rank (SJR)


The overall rank of Drug Discovery Today: Disease Models is 7950. According to SCImago Journal Rank (SJR), this journal is ranked 0.665. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Drug Discovery Today: Disease Models by Year


Year SJR
2023/2024 Coming Soon
2023 0.665
2022 0.315
2021 0.487
2020 0.268
2019 0.252
2018 0.207
2017 0.218
2016 0.479
2015 0.310
2014 0.373

Ranking of Drug Discovery Today: Disease Models by Year


Year Ranking
2023/2024 Coming Soon
2023 7950
2022 14651
2021 10244
2020 15926
2019 16081
2018 17484
2017 16468
2016 9605
2015 13099
2014 11183

Drug Discovery Today: Disease Models Publisher


Table Setting

Drug Discovery Today: Disease Models is published by Elsevier Ltd. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 2004-2020. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Drug Discovery Today: Disease Models is Drug Discov. Today: Dis. Models. This abbreviation ('Drug Discov. Today: Dis. Models') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Drug Discovery Today: Disease Models


If your research field is/are related to Drug Discovery (Q2); Molecular Medicine (Q3), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Drug Discovery Today: Disease Models?

Drug Discovery Today: Disease Models latest impact IF is 0.00. It's evaluated in the year 2023. The highest and the lowest impact IF or impact score of this journal are 1.78 (2022) and 0.00 (2023), respectively, in the last 10 years. Moreover, its average IS is 0.68 in the previous 10 years.


What's the SCImago Journal Rank (SJR) of the Drug Discovery Today: Disease Models?

The Drug Discovery Today: Disease Models has an SJR (SCImago Journal Rank) of 0.665, according to the latest data. It is computed in the year 2024. In the past 10 years, this journal has recorded a range of SJR, with the highest being 0.665 in 2023 and the lowest being 0.207 in 2018. Furthermore, the average SJR of the Drug Discovery Today: Disease Models over the previous 10-year period stands at 0.68.


What's the latest h-index of the Drug Discovery Today: Disease Models?

The latest h-index of the Drug Discovery Today: Disease Models is 33.


Who's the publisher of the Drug Discovery Today: Disease Models?

The Drug Discovery Today: Disease Models is published by the Elsevier Ltd, with its country of publication being the United Kingdom.


What's the current ranking of the Drug Discovery Today: Disease Models?

The Drug Discovery Today: Disease Models is currently ranked 7950 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 10 years, this journal has experienced varying rankings, reaching its highest position of 7950 in 2023 and its lowest position of 17484 in 2018.


What's the abbreviation or short name for the Drug Discovery Today: Disease Models?

The standard ISO4 abbreviation for the Drug Discovery Today: Disease Models is Drug Discov. Today: Dis. Models.


Is the "Drug Discovery Today: Disease Models" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Drug Discovery Today: Disease Models is classified as a journal that the Elsevier Ltd publishes.


What's the scope or major areas of the Drug Discovery Today: Disease Models?

The Drug Discovery Today: Disease Models encompasses the following areas:

  • Drug Discovery
  • Molecular Medicine

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Drug Discovery Today: Disease Models?

The Drug Discovery Today: Disease Models is assigned the following International Standard Serial Numbers (ISSN): 17406757.


What's the best quartile of the Drug Discovery Today: Disease Models?

The best quartile for the Drug Discovery Today: Disease Models is Q2 (2023).


What's the coverage history of the Drug Discovery Today: Disease Models?

The Drug Discovery Today: Disease Models coverage history can be summarized as follows: 2004-2020.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
European Union Politics journal 2569 SAGE Publications Ltd 75 3.24
Analysis in Theory and Applications journal 19346 Springer Netherlands 11 0.00
Proceedings of the Spring Technical Conference of the ASME Internal Combustion Engine Division conference and proceedings 17477 16 0.00
Applied Ecology and Environmental Research journal 18145 Corvinus University of Budapest 43 0.77
Clinical Medicine and Research journal 14722 Marshfield Clinic 62 1.02
Air and Space Power Journal (discontinued) journal 28397 AU Press 9 0.20
Materials Research journal 15375 Universidade Federal de Sao Carlos 71 1.46
Mathematical Modelling and Analysis journal 11193 Vilnius Gediminas Technical University 29 1.75
Canadian Journal of Education journal 18985 Canadian Society for the Study of Education (CSSE) 43 0.58
Abacus journal 5997 Wiley-Blackwell Publishing Ltd 53 2.75

Check complete list




Year wise Impact Score (IS) of Drug Discovery Today: Disease Models

Impact Score Table

Year Impact Score (IS)
2024/2025 Coming Soon
2023 0.00
2022 1.78
2021 1.20
2020 0.93
2019 0.46
2018 0.22
2017 0.37
2016 0.81
2015 0.63
2014 0.42



Top Journals/Conferences in Drug Discovery

Nature Reviews Drug Discovery
Nature Publishing Group | United Kingdom

Protein and Cell
Oxford University Press | United Kingdom

Molecular Therapy
Cell Press | United States

Medicinal Research Reviews
John Wiley & Sons Inc. | United States

Cell Chemical Biology
Elsevier Inc. | United States

Emerging Microbes and Infections
Taylor and Francis Ltd. | United Kingdom

Natural Product Reports
Royal Society of Chemistry | United Kingdom

Journal of Medicinal Chemistry
American Chemical Society | United States

MedComm
John Wiley and Sons Inc. | United States

Molecular Therapy - Nucleic Acids
Cell Press | United States

See All

Top Journals/Conferences in Molecular Medicine

Nature Biotechnology
Nature Publishing Group | United Kingdom

Cell Stem Cell
Cell Press | United States

Molecular Cancer
BioMed Central Ltd | United Kingdom

Pharmacological Reviews
American Society for Pharmacology and Experimental Therapeutics | United States

Genome Medicine
BioMed Central Ltd | United Kingdom

EMBO Molecular Medicine
Springer | United Kingdom

Molecular Therapy
Cell Press | United States

Journal for ImmunoTherapy of Cancer
BMJ Publishing Group | United Kingdom

Experimental and Molecular Medicine
Korean Society of Med. Biochemistry and Mol. Biology | South Korea

Trends in Molecular Medicine
Elsevier Ltd | United Kingdom

See All